MwanzoCYCCP • NASDAQ
add
Cyclacel Pharmaceuticals Inc Conv. Pref. Shrs
Bei iliyotangulia
$ 7.33
Bei za mwaka
$ 5.25 - $ 22.20
Thamani ya kampuni katika soko
2.03M USD
Wastani wa hisa zilizouzwa
370.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 4.00 | -98.93% |
Matumizi ya uendeshaji wa biashara | 3.65M | -42.11% |
Mapato halisi | -3.26M | 40.22% |
Kiwango cha faida halisi | elfu -81.42 | -5,474.80% |
Mapato kwa kila hisa | -0.72 | 89.09% |
EBITDA | -3.64M | 38.49% |
Asilimia ya kodi ya mapato | 11.23% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 6.00M | -40.97% |
Jumla ya mali | 8.19M | -50.19% |
Jumla ya dhima | 7.19M | -36.40% |
Jumla ya hisa | elfu 999.00 | — |
hisa zilizosalia | 1.97M | — |
Uwiano wa bei na thamani | 13.33 | — |
Faida inayotokana na mali | -126.92% | — |
Faida inayotokana mtaji | 1,542.76% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -3.26M | 40.22% |
Pesa kutokana na shughuli | -3.08M | -136.32% |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | 6.29M | 12,431.37% |
Mabadiliko halisi ya pesa taslimu | 3.20M | 351.93% |
Mtiririko huru wa pesa | -2.94M | -93.08% |
Kuhusu
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Berkeley Heights, New Jersey and Dundee, Scotland, developing cancer treatments. Cyclacel was founded in 1996 by David Lane, PhD. Wikipedia
Ilianzishwa
13 Ago 1996
Makao Makuu
Tovuti
Wafanyakazi
12
